LIG1 Loss Reveals Targetable Weakness Against Chemotherapy-Resistant Triple-Negative Breast Cancer
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1) ...
A new study in Nature Communications reveals how cancer cells can use the body’s own defenses against them. The work, ...
A groundbreaking study published in Nature Communications unveils a novel approach to treating brain metastases with unprecedented precision and efficacy. ...
In a groundbreaking phase 2 clinical trial, researchers have demonstrated the efficacy of olaparib, a PARP inhibitor, in treating metastatic ...
In a groundbreaking advancement poised to reshape the landscape of cancer diagnosis and treatment, researchers from a multidisciplinary team have ...
In a groundbreaking advancement in the field of oncology drug discovery, researchers have harnessed the power of deep learning to ...
In a groundbreaking systematic review published in the Journal of Translational Medicine, researchers led by Zhang and colleagues explore the ...
In a groundbreaking study published in Scientific Reports, researchers have unveiled a novel zinc complex that could revolutionize cancer treatment ...
A groundbreaking clinical study has unveiled a transformative biomarker that could revolutionize treatment strategies for recurrent prostate cancer patients post-surgery. ...
In a groundbreaking study, chemists from the Massachusetts Institute of Technology (MIT) have developed a novel approach to cancer treatment ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine